YLYandi Liu

Yandi Liu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yandi Liu has a total of 52 co-authors. Here are the top co-authors by number of shared publications:

  • Shiwu Zhang

    Department of Pathology, Tianjin Union Medical Center, Nankai University, Tianjin 300121, China

    7 shared publications
  • Jing Xu

    Department of General Surgery, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, China

    4 shared publications
  • Muran Li

    Department of Gastroenterology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, 300121, China.

    4 shared publications
  • Kai Liu

    Department of Research and Education, Tianjin Beichen Hospital, Tianjin, China

    3 shared publications
  • Man Yan

    Graduate School, Tianjin University of Traditional Chinese Medicine, Tianjin, P.R. China

    3 shared publications
  • Xuetao Dong

    Department of Gastroenterology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Tianjin, 300121, China

    3 shared publications

Latest Publications

  • Open Access

    Gender differences in the relationship between dynapenic abdominal obesity and non-neoplastic digestive system diseases among middle-aged and older adults

    by Xuetao Dong, Yan Zhang, Yandi Liu, Muran Li

    Non-neoplastic digestive system diseases (NNDSD) are highly prevalent among middle-aged and older adults and represent a substantial global health burden. Dynapenic abdominal obesity (DAO), a clinical phenotype characterized by low muscle strength (dynapenia) combined with abdominal obesity, has been associated with a range of chronic diseases. However, the prospective association between DAO and incident NNDSD has not yet been elucidated. This study aimed to examine the prospective association between DAO and the risk of new-onset NNDSD. A total of 5,956 participants from five waves of the China Health and Retirement Longitudinal Study were included in the present analysis. Participants were classified into four groups: non-dynapenic/non-abdominally obese (ND/NAO), abdominal obesity only (ND/AO), dynapenia only (D/NAO), and DAO. Multivariable Cox proportional hazards models were employed to evaluate the association between DAO and incident NNDSD. During a median 9-year follow-up, 1,082 incident cases of NNDSD were identified. In the overall population, participants with DAO exhibited a significantly higher risk of NNDSD than those in the ND/NAO group (HR = 1.597, 95% CI: 1.121-2.276). Notably, a pronounced sex-specific difference was observed. A significant association was observed among women (HR = 1.820, 95% CI: 1.235-2.683), whereas no significant association was identified among men. The coexistence of dynapenia and abdominal obesity was associated with an increased risk of incident NNDSD among middle-aged and older women, whereas no such association was observed among men. Early identification of the DAO phenotype may facilitate the implementation of targeted preventive interventions, including combined resistance and aerobic exercise programs, to reduce the risk of NNDSD.

  • Open Access

    Dynapenic Abdominal Obesity and the Risk of Non-Neoplastic Digestive System Diseases in Postmenopausal Women: A Prospective Cohort Study

    by Xuetao Dong, Yan Zhang, Chunxiao Zhang, Guodong Huang, Yandi Liu, Muran Li

    Background: Non-neoplastic digestive system diseases (NNDSD) are highly prevalent in older adults and impose a substantial health burden, particularly among postmenopausal women. Dynapenic abdominal obesity (DAO), characterized by the coexistence of reduced muscle strength and abdominal obesity, has been associated with a range of chronic diseases. However, its association with incident NNDSD in postmenopausal women remains insufficiently explored. This study aimed to explore the prospective association between DAO and incident NNDSD in postmenopausal women. Methods: This prospective cohort study included 2115 postmenopausal women drawn from five waves of the China Health and Retirement Longitudinal Study. Participants were classified into four mutually exclusive groups: non-dynapenic and non-abdominally obese (ND/NAO), abdominal obesity alone (ND/AO), dynapenia alone (D/NAO), and concurrent dynapenia and abdominal obesity (D/AO). Multivariable Cox proportional hazards models were used to evaluate the association between DAO and incident NNDSD, defined based on self-reported physician diagnoses obtained through standardized questionnaires. Results: Over a 9-year follow-up, 446 participants developed NNDSD. The incidence of NNDSD was highest among participants in the D/AO group. The D/AO group showed a significantly higher risk of NNDSD compared to the ND/NAO group (HR: 1.892, 95% CI: 1.256– 2.849). Subgroup and sensitivity analyses confirmed the robustness of these findings. Conclusion: DAO is independently associated with an increased risk of NNDSD in postmenopausal women. Given the observational nature of this study, the findings should be interpreted with caution and do not imply causality. Further prospective and interventional studies are warranted to confirm these associations and to evaluate their clinical and preventive implications.

  • Open Access

    KRAS and MYC synergistic inhibition: a powerful strategy targeting KRAS-mutant cancers

    by Man Yan, Kai Liu, Jing Xu, Yandi Liu, Liechen Ji, Shiwu Zhang

    KRAS is a critical proto-oncogene that encodes a protein functioning as a pivotal molecular switch in intracellular signaling. Both KRAS mutations and MYC


  • Open Access

    Endoscopic characteristics and clinical management of cap polyposis: Insights from seven cases

    by Jifang Cui, Luyao Zhao, Muran Li, Xiuqiang Huang, Yandi Liu

    Cap polyposis (CP) is an uncommon benign condition affecting the colorectal region. This study aimed to examine endoscopic features, therapeutic responses, and clinical outcomes of CP, with particular emphasis on the variable response to Helicobacter pylori eradication. This retrospective case series evaluated seven patients diagnosed with CP at Tianjin Union Medical Center between February 2018 and April 2023. The diagnosis was established based on distinctive endoscopic and histological findings, with clinical exclusion of other conditions such as ulcerative colitis (UC) and solitary rectal ulcer syndrome. Clinical data, endoscopic characteristics, treatments, and outcomes were systematically reviewed. This case series included seven patients (six males, one female) with a median age of 36 years. Four patients were H. pylori-positive. All patients exhibited characteristic sessile or semi-pedunculated polyps covered by a whitish fibrinopurulent cap, predominantly located in the rectosigmoid region with normal intervening mucosa. Treatment outcomes varied. Two H. pylori-positive patients with short disease duration achieved complete remission following eradication therapy combined with polypectomy. Two other H. pylori-positive patients showed only initial improvement after eradication, with subsequent recurrences; one ultimately required total colectomy due to disease progression. In contrast, one H. pylori-negative patient achieved remission through polypectomy and medical therapy alone. CP poses significant diagnostic challenges and demonstrates heterogeneous responses to treatment. Eradication of H. pylori may prove effective in certain patients with early-stage disease. Therefore, timely diagnosis and personalized treatment strategies, including endoscopic resection, are essential for achieving favorable outcomes.


  • Open Access

    Cross-talk between cancer-associated fibroblasts and dormant cancer cells: current status and promising therapeutic potential

    by Jiayue Liu, Yue Zhang, Kai Liu, Jialong Shi, Man Yan, Jing Xu, Yandi Liu, Shiwu Zhang

    Cancer-associated stromal cells, particularly cancer-associated fibroblasts (CAFs), are pivotal components of the tumor microenvironment (TME) that signifi


  • Activated PLK1 promotes the migration and invasion of polyploid giant cancer cells with daughter cells via β-catenin/STAT3 signaling pathway

    by Xinyue Zhou, Yidi Ning, Xiaorui Wang, Jing Xu, Yandi Liu, Mingqing Zhang, Shiwu Zhang

    The abundance of polyploid giant cancer cells (PGCCs) is correlated with malignant tumor progression. PGCCs divide asymmetrically to generate daughter cells with high invasive and migratory capacities. The objective of this study was to investigate the mechanism by which the overexpression of polo-like kinase 1 (PLK1) regulates the migration and invasion of PGCCs and their daughter cells (PDCs). In the present study, PGCC formation was induced by CoCl2 in Hct116 and LoVo cells. The mRNA expression and protein levels were detected using reverse transcription‒quantitative PCR and western blotting, respectively. The regulatory relationships among related proteins were determined via small molecule inhibitors, transient small interfering RNA (siRNA) transfection, and coimmunoprecipitation. Our findings indicated that CoCl2 induces PGCC formation and produces progeny cells with increased invasive and metastatic abilities. PLK1 was expressed in PDCs and showed altered subcellular localization. In addition, aurora kinase A (AURKA) activated PLK1 by phosphorylating it at serine 137 and threonine 210. Activated PLK1 first stabilizes β-catenin accumulation in the cytoplasm and subsequently promotes its entry into the nucleus. After entering the nucleus, β-catenin promotes the accumulation of the tyrosine 705 site of signal transducer and activator of transcription 3 (pSTAT3–Tyr705), which promotes the downstream expression of target proteins, such as cyclin D1, matrix metallopeptidase 2 (MMP2) and c-MYC, and EMT-associated proteins as transcription factors. Furthermore, STAT3 and PLK1 form a feedback loop, allowing STAT3 to regulate PLK1 expression. In conclusion, PLK1 phosphorylation at different sites regulates the transcriptional function of pSTAT3–Tyr705 by promoting β-catenin nuclear translocation. Furthermore, AURKA and STAT3 affected PLK1 expression.


  • Open Access

    Intestinal epithelial glycocalyx and intestinal disease

    by Jian-Wei Gao, Yan-Di Liu, Ming-Xing Jin

    随着对糖生物学的不断研究, 发现越来越多的疾病与糖萼相关. 糖萼根据所在部位不同, 大致可分为内皮糖萼与上皮糖萼. 在过去的研究中多为内皮糖萼, 本综述主要介绍肠上皮糖萼的生物学特性、其降解机制、与肠道不同疾病的生物相关性以及模拟糖萼的纳米颗粒文库对器官的靶向递送药物等方面进行分析, 以期为肠上皮糖萼在肠道疾病中潜在的诊断标志物以及治疗靶点的研究提供理论依据.

  • Open Access

    The stool syndecan2 methylation test is more robust than blood tests for methylated septin9, CEA, CA19-9 and CA724: a diagnostic test for the early detection of colorectal neoplasms

    by Yixiang Zhan, Shuyuan Wang, Zhen Yuan, Xuanzhu Zhao, Kemin Ni, Ran Xin, Xingyu Zhou, Zhaoce Liu, Xin Yin, Hangyu Ping, et al.

    Case Report Endometrial stromal sarcoma metastatic to the inferior vena cava: a case report and literature review Ying Zhang, Zhiyong Wei, Jia Yan, Keliang Xie, Zhiqiang Wang


  • Open Access

    Plasma-Methylated SEPT9 for the Noninvasive Diagnosis of Gastric Cancer

    by Luyao Zhao, Muran Li, Shiwu Zhang, Yandi Liu

    Background. Gastric cancer (GC) is one of the most prevalent cancers globally. This study was designed to evaluate the potential performance of plasma SEPT9 methylation (mSEPT9) as a noninvasive biomarker for the diagnosis of GC. Methods. A total of 182 participants, i.e., 60 patients with GC, 39 with chronic superficial gastritis (CSG), 27 with chronic atrophic gastritis (CAG), 30 with gastric ulcer (GU), and 26 with gastric polys (GP), were recruited. The mSEPT9 level was measured using real-time polymerase chain reaction. Results. As a diagnostic target, mSEPT9 (1/3 algorithm) had a sensitivity of 48.33 (95% confidence interval (CI): 35.40–61.48%) and a specificity of 86.89% (95% CI: 79.28–92.09%), and mSEPT9 (2/3 algorithm) had a sensitivity of 33.33 (95% CI: 22.02–46.79%) and a specificity of 98.36% (95% CI: 93.61–99.72%). The area under the receiver operating characteristic curve (ROC) curve of mSEPT9 was 0.698 (95% CI: 0.609–0.787) for the differentiation of GC from benign gastric diseases. The effectiveness of mSEPT9 (1/3 algorithm) was superior to that of CEA, CA19-9, and CA72-4. mSEPT9 was positively correlated with T, N, M, and the clinical stage of GC. Conclusions. Plasma mSEPT9 might serve as a useful and noninvasive biomarker for the diagnosis of GC.